Note 11 - Related Party Transactions
|6 Months Ended|
Jun. 30, 2019
|Notes to Financial Statements|
|Related Party Transactions Disclosure [Text Block]||
The Company uses Moores Cancer Center at the University of California San Diego (UCSD) to provide pharmacology lab services to the Company. Dr. Stephen Howell is the Acting Chief Medical Officer of Aptose and is also a Professor of Medicine at UCSD and oversees the laboratory work. The work is completed under the terms of research services agreements executed in
March 2015and has been extended annually. In
March 2019,the Board approved an extension of this agreement for
twelvemonths for services up to
$300,000.These transactions are in the normal course of business and are measured at the amount of consideration established and agreed to by the related parties.
June 30, 2019,the Company recorded
$143thousand) in research and development expenses related to the agreement.
No definition available.
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef